Evidence for cholinesterase-inhibitor therapy for dementia associated with Parkinson's disease.
Boeve
Bradley F
BF
Division of Behavioral Neurology, Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, 200 First Street SW, Rochester, Minnesota 55905, USA. bboeve@mayo.edu <bboeve@mayo.edu>
D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003704:Dementia / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D020961:Lewy Body Disease / Q000188:drug therapy / Q000209:etiology; D010300:Parkinson Disease / Q000523:psychology*; D048448:Phenylcarbamates / Q000627:therapeutic use; D000068836:Rivastigmine
D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D000068836:Rivastigmine